Verastem Priced, Nasdaq: VSTM
Pre-clinical stage biotech developing stem cell therapies for metastatic cancers.
Industry: Health Care
First Day Return: +10.9%
Industry: Health Care
VSTM
Pre-clinical stage biotech developing stem cell therapies for metastatic cancers.
| IPO Data | |
|---|---|
| IPO File Date | 11/03/2011 |
| Offer Price | $10.00 |
| Price Range $9.00 - $11.00 | |
| Offer Shares (mm) | 5.5 |
| Deal Size ($mm) | $55 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 01/26/2012 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $55 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Cambridge, MA, United States |
| Founded | 2010 |
| Employees at IPO | 18 |
| Website www.verastem.com | |
IPO News for Verastem
Verastem (VSTM) Performance
